Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

BetterMe Rx vs Royal Medical Center

BetterMe Rx
Graded #235

Higher grade

vs+15.500000000000007
Royal Medical Center
Graded #492

Lower grade

The verdict

BetterMe Rx takes it — 64.9/100 to 49.4/100.

BetterMe Rx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. BetterMe Rx offers compounded semaglutide ($199/mo) and tirzepatide ($299/mo) in both injectable and oral daily tablet formats.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueBetterMe Rx +22
44
22
Dose & formulationBetterMe Rx +33
75
42
Clinical oversightBetterMe Rx +22
84
62
Labs & monitoringRoyal Medical Center +34
52
86
FulfillmentBetterMe Rx +40
88
48
Contract termsRoyal Medical Center +8
47
55
BetterMe Rx · left barRoyal Medical Center · right bar

The numbers

MetricBetterMe RxRoyal Medical Center
WeighScore64.9/10049.4/100
GradeCC
Scorecard rank#235#492
Semaglutide$199/mo (promotional rate, compounded)Not disclosed
Tirzepatide$299/mo (promotional rate, compounded)$450/mo (2.5 mg dose, compounded)
CoverageAll 50 statesCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualYesInjection only
BetterMe Rx

Graded #235 · C

Strengths

  • LegitScript verified
  • All 50 states coverage
  • Six named pharmacy partners with phone numbers — exceptional transparency
  • Both injectable and oral daily tablet formats for sema and tirz
  • Multi-month discounts (3-month and 6-month plans)

Where it loses points

  • No formal corporate entity name or address disclosed
  • Compounded only — no brand-name options
  • Broader platform (HRT, ED, NAD+, Sermorelin, skincare)
  • Headline $199/$299 are limited-time SALE prices; regular prices are $249/$349 per month
Royal Medical Center

Graded #492 · C

Strengths

  • Physician founder Dr. Dagoberto Rodriguez, MD — Emory residency, former Coral Springs Medical Center chairman, U Miami faculty
  • Tirzepatide pricing fully itemized by dose tier ($450 / $650 / $800 / $1,100) — more transparent than 'starting at' floors
  • All-inclusive pricing bundles medication, supplies, injections, lab monitoring, and physician follow-ups
  • Broad catalog (HRT, TRT, peptides, ED, hair, vitamins) reflects an established multi-program clinic
  • Florida physician with 30+ years of practice — a strong physician-led care signal

Where it loses points

  • Operating legal entity not disclosed — only the 'Royal Medical Center' brand surfaced
  • Pharmacy partner not named — buyers can't verify licensure or 503A/503B status
  • No LegitScript badge displayed
  • States served not enumerated — site says 'nationwide' with no state list
  • Headline 'starting at $116/mo' conflicts with the actual $450/mo tirzepatide floor

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard